Concourse Financial Group Securities’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-570
| Closed | -$2.08K | – | 10282 |
|
|
2024
Q4 | $2.08K | Hold |
570
| – | – | ﹤0.01% | 2011 |
|
|
2024
Q3 | $2.96K | Hold |
570
| – | – | ﹤0.01% | 1947 |
|
|
2024
Q2 | $1.46K | Hold |
570
| – | – | ﹤0.01% | 2074 |
|
|
2024
Q1 | $2.8K | Buy |
+570
| New | +$2.8K | ﹤0.01% | 1998 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9140 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8910 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8697 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 8365 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8373 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8192 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8046 |
|
|
2022
Q1 | – | Sell |
-500
| Closed | -$8K | – | 7860 |
|
|
2021
Q4 | $8K | Hold |
500
| – | – | ﹤0.01% | 1937 |
|
|
2021
Q3 | $14K | Hold |
500
| – | – | ﹤0.01% | 1788 |
|
|
2021
Q2 | $15K | Hold |
500
| – | – | ﹤0.01% | 1741 |
|
|
2021
Q1 | $14K | Hold |
500
| – | – | ﹤0.01% | 1676 |
|
|
2020
Q4 | $14K | Hold |
500
| – | – | ﹤0.01% | 1586 |
|
|
2020
Q3 | $13K | Hold |
500
| – | – | ﹤0.01% | 1501 |
|
|
2020
Q2 | $12K | Buy |
+500
| New | +$12K | ﹤0.01% | 1444 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6136 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6048 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5899 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5906 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5800 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5715 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5562 |
|